TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
77.20
-5.72 (-6.90%)
At close: Nov 20, 2024, 4:00 PM
77.00
-0.20 (-0.26%)
Pre-market: Nov 21, 2024, 7:41 AM EST
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $2.59 billion as of November 21, 2024. Its market cap has increased by 30.68% in one year.
Market Cap
2.59B
Enterprise Value
2.78B
1-Year Change
30.68%
Ranking
Category
Stock Price
$77.20
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $2.59B, an increase of 472.61%. That is a compound annual growth rate of 36.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.59B | 0.55% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | 540.50M | 34.35% |
| Dec 31, 2019 | 402.32M | -11.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 2.84B |
| ACADIA Pharmaceuticals | 2.83B |
| Surgery Partners | 2.76B |
| Kymera Therapeutics | 2.75B |
| Warby Parker | 2.75B |
| LifeStance Health Group | 2.68B |
| Concentra Group Holdings Parent | 2.64B |
| PACS Group | 2.63B |